Press release
Anti-Diuretic Drugs Market: 2024 Industry Size, Shares, Segment & Forecast up to 2032
The global anti-diuretic drugs market reached a valuation of USD 494.13 million in 2023 and is expected to experience a robust growth rate, registering a compound annual growth rate (CAGR) of 13.4% throughout the forecast period. This steady market growth is attributed to a variety of factors including the increasing geriatric population affected by diabetes insipidus, ongoing clinical trials, and approvals of new drugs by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).Anti-diuretic drugs are primarily used to treat diabetes insipidus, a condition caused by low levels of the antidiuretic hormone (ADH) in the body. These drugs play a vital role in managing the excessive urination and thirst associated with the condition. With advancements in medical technology, clinical trials for anti-diuretic drugs have progressed significantly, making the treatment more effective for patients with diabetes insipidus.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2907
Key Market Drivers
One of the main factors driving the growth of the anti-diuretic drugs market is the rising number of diabetes cases globally. According to the International Diabetes Federation (IDF), around 537 million adults worldwide live with diabetes, and this number is expected to reach 783 million by 2045. The increasing prevalence of diabetes is expected to raise the demand for anti-diuretic drugs in the coming years.
Additionally, leading pharmaceutical companies are upgrading their product portfolios, which is also contributing to market growth. For example, Amphastar Pharmaceuticals, Inc. received FDA approval in July 2022 for its Vasopressin injection, a drug used in treating conditions like diabetes insipidus. These new product launches and approvals are expected to strengthen the market's growth trajectory.
Another key growth driver is the rising demand for desmopressin analogs, which are synthetic forms of the vasopressin hormone. Desmopressin is used to manage dehydration, control excessive urination, and reduce increased thirst. The availability of desmopressin in various forms, such as nasal sprays and tablets, has made it easier for healthcare providers and patients to adopt the treatment, further driving the market's expansion.
Geriatric Population and Rising Diabetes Insipidus Cases
The aging population is also a significant factor in the growth of the anti-diuretic drugs market. Older individuals are more prone to conditions like diabetes insipidus, and the rising life expectancy is increasing the demand for effective treatment options. According to the World Health Organization, by 2030, 1 in 6 people worldwide will be aged 60 years or older, with the number doubling to 2.1 billion by 2050. This growing elderly population, particularly those affected by diabetes insipidus, is driving market growth.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/anti-diuretic-drugs-market
Challenges Facing the Market
Despite these growth factors, the anti-diuretic drugs market faces some challenges. One of the major restraints is the potential side effects of vasopressin, which can lead to complications such as asthma, heart disease, and heart failure. These risks may cause patients to be hesitant about undergoing treatment, thereby limiting the market's growth.
Market Segmentation Insights
In terms of product types, the vasopressin segment accounted for the largest share of the market in 2023, largely due to its essential role in preventing dehydration by mimicking ADH's effect on the kidneys. Desmopressin, a synthetic form of vasopressin, is also expected to see strong growth due to its higher anti-diuretic effect and lower risk of side effects compared to vasopressin.
When it comes to applications, diabetes insipidus is the leading segment, accounting for the largest revenue share. The rising number of diabetes insipidus cases worldwide is expected to continue driving this segment's dominance in the market.
Distribution Channels
The hospital pharmacies segment led the market in 2023, benefiting from the increasing number of hospital admissions for urological conditions associated with diabetes insipidus. Meanwhile, the online pharmacy segment is expected to grow at a strong CAGR due to increasing internet penetration and the convenience of online drug purchases.
Anti-Diuretic Drugs Top Companies and Competitive Landscape
The global anti-diuretic drugs market is fairly fragmented, with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective solutions.
Some major players included in the global anti-diuretic drugs market report are:
Par Sterile Products, LLC.
Pfizer Inc.
ADH Health
Otsuka Holdings Co., Ltd.
Azevan Pharmaceuticals, Inc.
Taj Pharmaceuticals Limited.
Endo International
Ferring Pharmaceuticals
Fresenius Kabi.
Hybio Pharmaceutical.
Hainan Zhonghe Pharmaceutical.
Avadel
Hoffman-La Roche Ltd
CSL Limited.
Bayer
Eisai Co., Ltd.
Allergan
Sanofi S.A
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Other companies
Anti-Diuretic Drugs Latest Industry Updates
On February 2022, Dr. Reddy's Laboratories announced the launch of its authorized generic version of VASOSTRICT (vasopressin injection, USP) vials U.S. Market, to expand their geographical across U.S. The product is approved by the U.S. Food and Drug Administration (USFDA).
On February 25, 2020, Lupin announced the launch of Ethacrynic Acid Tablets USP, 25 mg, after the receiving approval from United States Food and Drug Administration (U.S. FDA)
Anti-Diuretic Drugs Market Segmentation Analysis
For the purpose of this report, Emergen Research has segmented global anti-diuretic drugs market on the basis of Type, Application, Distribution Channel, and region:
Type Outlook (Revenue, USD Million; 2020-2033)
Oxytocin
Vasopressin
Desmopressin
Application Outlook (Revenue, USD Million; 2020-2033)
Diabetes Insipidus
Hemophilia
Hypertension
Others
Distribution Channel Outlook (Revenue, USD Million; 2020-2033)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2907
Regional Outlook (Revenue, USD Million; 2020-2033)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Anti-Diuretic Drugs Market Snapshots
Anti-Diuretic Drugs Market Size: https://www.emergenresearch.com/industry-report/anti-diuretic-drugs-market/market-size
Anti-Diuretic Drugs Market Share: https://www.emergenresearch.com/industry-report/anti-diuretic-drugs-market/market-share
Anti-Diuretic Drugs Market Trends: https://www.emergenresearch.com/industry-report/anti-diuretic-drugs-market/market-trends
Anti-Diuretic Drugs Regional Market Demand: https://www.emergenresearch.com/industry-report/anti-diuretic-drugs-market/regional-market-demand
Anti-Diuretic Drugs Market Analysis: https://www.emergenresearch.com/industry-report/anti-diuretic-drugs-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Diuretic Drugs Market: 2024 Industry Size, Shares, Segment & Forecast up to 2032 here
News-ID: 3676688 • Views: …
More Releases from Emergen Research

Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…

Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…

Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…

Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…